HLA-G5 in the blood of leukemia patients and healthy individuals
Authors:
- Tatiana ŽelezníkováTŽTatiana Železníková
- Gustáv RussGRGustáv Russ
- 1 February 2013
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 37 (2) , 139-145
Abstract
No abstract availableKeywords
Funding Information
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (2/0124/11)
- Slovenská Akadémia Vied
This publication has 52 references indexed in Scilit:
- Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease associationCellular and Molecular Life Sciences, 2010
- Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Cellular and Molecular Life Sciences, 2010
- Low Expression of Human Histocompatibility Soluble Leukocyte Antigen-G (HLA-G5) in Invasive Cervical Cancer With and Without Metastasis, Associated With Papilloma Virus (HPV)Journal of Histochemistry & Cytochemistry, 2009
- HLA-G: a human pregnancy-related immunomodulatorCurrent Opinion in Pharmacology, 2009
- Activation of HLA-G expression by 5-aza-2´- deoxycytidine in malignant hematopoetic cells isolated from leukemia patientsNeoplasma, 2009
- Expression of functional soluble human leucocyte antigen‐G molecules in lymphoproliferative disordersBritish Journal of Haematology, 2007
- Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancerLaboratory Investigation, 2007
- Soluble HLA-G Molecules Are Increased during Acute Leukemia, Especially in Subtypes Affecting Monocytic and Lymphoid Lineages'Neoplasia, 2006
- HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaBlood, 2005
- HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinomaGynecologic Oncology, 2005